IRCCS Istituto Auxologico Italiano
Milan, MI, 20122, Italy
Location status: Recruiting
NCT Number: NCT06296420
The goal of this observational study is to develop a questionnaire for measuring swallowing and throat discomfort symptoms in patients with goiter or thyroidectomy, which complies with the model of Rasch and which satisfies the fundamental measurement axioms (e.g., unidimensionality, linearity, generalizability). Developing a scale with such characteristics would provide clinicians and researchers with a reliable tool for assessing the impact of goiter and for measuring the outcomes after surgery.
Also, the study will assess the psychological impact of goiter and thyroidectomy, as well as the characteristics of the surgical scar after thyroidectomy.
The questionnaire will be developed in the first phase of the study. Items and response categories will be identified through interviews performed with patients affected by goiter or after thyroidectomy.
In the following phases of the study, the questionnaire will be administered to patients before and after thyroidectomy.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Milan, MI, 20122, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: In the week before surgery, three months after surgery, and six months after surgery.
The questionnaire will be administered to the recruited patients three times: in the week before surgery, three months after surgery, and six months after surgery.
Time frame: The POSAS 2.0 will be administered 10 days after surgery and 2 months after surgery.
The Patient and Observer Scar Assessment Scale (POSAS) 2.0. is an assessment scale that measures the quality of the scar from the perspectives of the patient and the clinician. It is made of two separate subscales, i.e., the Observer Scar Assessment Scale and the Patient Scar Assessment Scale. The Observer Scar Assessment Scale is made of 6 items, each scored 1 to 10 (total score 6 to 60, with higher scores indicating worse scar quality). The Patient Scar Assessment Scale is made of 7 items, each scored 1 to 10, divided in three subsets (total score 7 to 70, with higher scores indicating worse scar quality).
Time frame: The DASS-21 will be administered 10 days before surgery and 2 months after surgery.
The Depression Anxiety Stress Scales-21 (DASS-21) is an assessment scale used to measure the severity of symptoms of depression, anxiety and stress. It is made of 21 items, each scored 0 to 3 (total score 0 to 63, with higher scores for greater severity of depression, anxiety and/or stress.
Contact information is provided by the study sponsor or research team.
Gianlorenzo Dionigi, MD
CONTACT
Stefano Scarano, MD
CONTACT
Istituto Auxologico Italiano
Other
Acronym: DYSPHATHYR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07575243
Endocrine Gland Neoplasms, Endocrine System Diseases
Asyut, Asyut Governorate, Egypt
View Trial DetailsNCT05434715
Endocrine System Diseases, Goiter
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
View Trial DetailsNCT02651818
Endocrine System Diseases, Goiter
Odense, Denmark
View Trial DetailsNCT00400465
Autoimmune Diseases, Endocrine Gland Neoplasms
Muang, Khonkaen, Thailand
View Trial Details